Viewing Study NCT00703066

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:20 PM
Ignite Modification Date: 2026-02-02 @ 6:19 PM
Study NCT ID: NCT00703066
Status: UNKNOWN
Last Update Posted: 2008-11-25
First Post: 2008-06-20
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Safety and Immunogenicity of 30 and 100 µg of GMZ2 in Gabonese Children Aged 1-5 Years
Sponsor: African Malaria Network Trust
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Malaria View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Malaria View
None Vaccine View
None GMZ2 View
None Safety View
None African View
None immunogenicity View